4.6 Article

TERT Promoter Mutation Analysis of Whole-Organ Mapping Bladder Cancers

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Bladder Tumor Subtype Commitment Occurs in Carcinoma In Situ Driven by Key Signaling Pathways Including ECM Remodeling

Adrian Wullweber et al.

Summary: The study reveals that CIS is the stage of commitment for determining MIBC tumor subtype, which is crucial for patient prognosis and therapy response.

CANCER RESEARCH (2021)

Review Biochemistry & Molecular Biology

Telomeres: history, health, and hallmarks of aging

Deepavali Chakravarti et al.

Summary: The escalating social and economic burden of an aging world population has brought aging research into the spotlight. Through the lens of telomere biology, we can better understand the mechanisms of aging and the development of age-related diseases, providing insights for prevention and treatment.
Article Medical Laboratory Technology

Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer

Sebastian Stasik et al.

CLINICAL BIOCHEMISTRY (2019)

Article Urology & Nephrology

Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis

Cagatay Guenes et al.

NATURE REVIEWS UROLOGY (2018)

Review Pathology

Origins of Bladder Cancer

Bogdan Czerniak et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)

Article Genetics & Heredity

Identification of neutral tumor evolution across cancer types

Marc J. Williams et al.

NATURE GENETICS (2016)

Article Multidisciplinary Sciences

TERT promoter mutations and telomerase reactivation in urothelial cancer

Sumit Borah et al.

SCIENCE (2015)

Review Urology & Nephrology

Epidemiology and Risk Factors of Urothelial Bladder Cancer

Maximilian Burger et al.

EUROPEAN UROLOGY (2013)

Review Oncology

Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies

C Hafner et al.

INTERNATIONAL JOURNAL OF CANCER (2002)